Clinical Biostatistics & Data Analysis

Collaborating With Sites to Prevent Avoidable Missingness

November 18, 2025November 15, 2025 digi

Collaborating With Sites to Prevent Avoidable Missingness Collaborating With Sites to Prevent Avoidable Missingness The efficient management of clinical trials is crucial in any oncology clinical research study. Among the various challenges faced, missing data emerges as one of the primary concerns that can significantly undermine the integrity of research results. This guide serves as…

Missing Data Strategies & Sensitivity Analyses

Coding Protocol Deviations Related to Missing Data Consistently

November 18, 2025November 15, 2025 digi

Coding Protocol Deviations Related to Missing Data Consistently Coding Protocol Deviations Related to Missing Data Consistently Introduction to Missing Data in Clinical Trials In the realm of clinical trials, data integrity and completeness are paramount. Missing data can lead to biased results and erroneous conclusions, thereby compromising the validity of clinical research. As clinical operations,…

Missing Data Strategies & Sensitivity Analyses

Integrating Missing Data Strategies With Estimands and Intercurrent Events

November 18, 2025November 15, 2025 digi

Integrating Missing Data Strategies With Estimands and Intercurrent Events Introduction In clinical trials, effective management of missing data is crucial for the validity and credibility of study results. The increasing complexity of clinical trial designs, particularly in areas such as schizophrenia clinical trials, necessitates robust strategies to address missing data, ensuring that conclusions drawn from…

Missing Data Strategies & Sensitivity Analyses

Documentation of Missing Data Assumptions for Health Authorities

November 18, 2025November 15, 2025 digi

Documentation of Missing Data Assumptions for Health Authorities Missing data in clinical trials is a prevalent challenge that can significantly impact the validity and reliability of study results. Therefore, it is crucial to implement a robust data management plan for clinical trials to address this issue effectively. This article serves as a step-by-step tutorial designed…

Missing Data Strategies & Sensitivity Analyses

Planning and Interpreting Subgroup Analyses—Without P-Hacking

November 18, 2025November 15, 2025 digi

Planning and Interpreting Subgroup Analyses—Without P-Hacking Planning and Interpreting Subgroup Analyses—Without P-Hacking Subgroup analyses play a critical role in clinical trials, providing insight into the variability of treatment effects across different patient populations. However, these analyses must be approached with caution to avoid misleading conclusions or “P-hacking,” a practice that can undermine the integrity of…

Multiplicity & Subgroup Analyses

Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods

November 18, 2025November 15, 2025 digi

Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods In the landscape of clinical research and trials, managing the statistical challenges related to multiple comparisons is crucial for maintaining the integrity and validity of the conclusions drawn from trial data. This article serves as a comprehensive step-by-step guide aiming to…

Multiplicity & Subgroup Analyses

Hierarchical Testing Strategies for Primary and Secondary Endpoints

November 18, 2025November 15, 2025 digi

Hierarchical Testing Strategies for Primary and Secondary Endpoints Hierarchical Testing Strategies for Primary and Secondary Endpoints In the realm of clinical research and trials, addressing multiplicity—specifically in the context of primary and secondary endpoints—is vital for ensuring robust statistical results and regulatory compliance. This tutorial provides a comprehensive step-by-step guide tailored for clinical operations, regulatory…

Multiplicity & Subgroup Analyses

Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs

November 18, 2025November 15, 2025 digi

Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs In the realm of clinical research and trials, managing multiplicity effectively is essential for ensuring the reliability and validity of trial outcomes. This article aims to provide a comprehensive guide for professionals in clinical operations,…

Multiplicity & Subgroup Analyses

Regulatory Expectations on Claims Based on Subgroup Findings

November 18, 2025November 15, 2025 digi

Regulatory Expectations on Claims Based on Subgroup Findings In the ever-evolving landscape of clinical trials, subgroup analyses play an essential role in understanding the nuanced effects of treatments across different patient demographics. However, with the advantages provided by such analyses come significant regulatory expectations. This guide aims to elucidate best practices and recommendations for conducting…

Multiplicity & Subgroup Analyses

Visualizing Subgroup Results for Clinicians, Executives and Regulators

November 18, 2025November 15, 2025 digi

Visualizing Subgroup Results for Clinicians, Executives, and Regulators In clinical research, performing effective subgroup analyses is crucial for understanding how different segments of a population respond to an intervention. This is particularly relevant for trials assessing therapeutic options with varied mechanisms of action and diverse participant demographics. Visualizations serve as powerful tools for conveying complex…

Multiplicity & Subgroup Analyses